Stifel Maintains Buy on Hinge Health, Raises Price Target to $115

Benzinga Newsdesk www.benzinga.com Positive 75.0%

Neg 0% Neu 0% Pos 75%

Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $96 to $115.